Professor Sir Munir Pirmohamed has been appointed by the Secretary of State for Health and Social Care as Chair of the Commission on Human Medicines (CHM).
Commission On Human Medicines
- Guidance: Coronavirus (COVID-19) testing service for extra care and supported living settings
- Notice: TN3 0LE, Mr Guy Harman: environmental permit application advertisement- EPR/UB3095WN/A001
- Notice: RH13 0RE, Mr Brian Cobden: environmental permit application advertisement- EPR/UB3095ED/A001
- Notice: HR4 7QF, National Trust: environmental permit application advertisement- EPR/TB3494AY/A001
- Notice: TR11 5UF, Windsport International Limited: environmental permit application advertisement - EPR/TB3696RJ/A001
- Notice: HR1 2NH, Friends of Castle Green: environmental permit application advertisement- EPR/TB3695WB/A001
- Guidance: Organisation testing registration: record of users
- Guidance: UK: tuberculosis test clinics for Hong Kong BN(O)
- Confirm your information and apply
- Scheme rules and other guidance
The Expert Working Group was set up to to identify ways to improve data collection and access to information relevant to research on medicines used during pregnancy and breastfeeding.
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the benefit-risk and risk minimisation measures of the yellow fever vaccine.
Minutes of the meeting and MHRA assessment report
Minutes of the meeting and MHRA assessment report.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
An Expert Working Group (EWG) of the UK’s Commission on Human Medicines (CHM) has published their report on the use of hormone pregnancy tests (HPTs) and adverse effects relating to pregnancy including possible birth defects.
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments